Important Information for ModivCare Securities Holders: Rosen Law Firm Announces Class Action Lawsuit and Lead Plaintiff Deadline
New York, NY – Rosen Law Firm, a global investor rights law firm, is reminding purchasers of ModivCare Inc. (MODV) securities between November 3, 2022, and September 15, 2024, to take note of the upcoming March 31, 2025, lead plaintiff deadline in the securities class action lawsuit. The lawsuit alleges that ModivCare and certain of its top executives made false and misleading statements and failed to disclose material information to investors.
What is the Class Action Lawsuit About?
The lawsuit alleges that ModivCare and its executives made false and misleading statements and failed to disclose material information regarding the company’s business, operations, and financial condition, including:
- The effectiveness of the company’s business model
- The adequacy of the company’s internal controls
- The company’s financial results and prospects
As a result of these alleged misrepresentations, ModivCare securities traded at artificially inflated prices during the Class Period, and when the truth was revealed, investors suffered significant losses.
How Does This Affect Me as a ModivCare Securities Holder?
If you purchased ModivCare securities during the Class Period, you may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. The lead plaintiff deadline, which is a critical deadline for securities class action lawsuits, is fast approaching. To be eligible to serve as the lead plaintiff, you must meet certain legal requirements and act quickly. The lead plaintiff is a representative party acting on behalf of all other class members in the lawsuit.
How Will This Affect the World?
The outcome of this lawsuit could have significant implications for the securities industry and investor protection. If the allegations are proven true, it could lead to increased scrutiny of publicly traded companies and their executives, as well as increased investor awareness of the importance of accurate and transparent disclosures. Additionally, it could result in significant financial damages for ModivCare and its executives, potentially deterring similar behavior in the future.
Conclusion
If you purchased ModivCare securities during the Class Period and believe you may be entitled to compensation, we encourage you to contact Rosen Law Firm as soon as possible to discuss your potential legal rights. The lead plaintiff deadline is fast approaching, and time is of the essence. Our experienced securities litigation team will provide you with a free, confidential consultation to help you understand your options and protect your investor rights.
At Rosen Law Firm, we are committed to ensuring that investors receive the compensation they are entitled to under the law. We have a long history of successfully recovering damages for investors in securities class actions, and we are dedicated to fighting for investor protection and holding wrongdoers accountable. Contact us today to learn more.
Disclaimer: This press release is an advertisement and informational in nature. Rosen Law Firm has not filed a lawsuit against ModivCare Inc. yet, but is investigating the securities class action. The information in this press release is not intended as legal or investment advice or a solicitation for business.
